Cargando…

A re-irradiation dose of 55–60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy

INTRODUCTION: Local recurrence (LR) is clinical challenge in the treatment of esophageal squamous cell carcinoma (ESCC). The current study aimed to determine the optimal re-irradiation dose for local recurrent esophageal squamous cell carcinoma (LRESCC) following radical (chemo) radiotherapy. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xun, Hu, Xingsheng, Chen, Junru, He, Lang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186078/ https://www.ncbi.nlm.nih.gov/pubmed/34103059 http://dx.doi.org/10.1186/s13014-021-01828-z

Ejemplares similares

Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy
por: Xu, Xiujuan, et al.
Publicado: (2019)

Hyperfractionated radiotherapy for re-irradiation of recurrent esophageal cancer
por: Takeda, Kazuya, et al.
Publicado: (2021)

Hypofractionated High-Dose Intensity-Modulated Radiotherapy (60 Gy at 2.5 Gy per Fraction) for Recurrent Renal Cell Carcinoma: A Case Report
por: Cho, Jaeho, et al.
Publicado: (2008)

Comparison of the effects of radiotherapy doses of 50.4 Gy and 60 Gy on outcomes of chemoradiotherapy for thoracic esophageal cancer: subgroup analysis based on the Comprehensive Registry of Esophageal Cancer in Japan from 2009 to 2011 by the Japan Esophageal Society
por: Nemoto, Kenji, et al.
Publicado: (2020)

Re-irradiation of recurrent esophageal cancer after primary definitive radiotherapy
por: Kim, Young Suk, et al.
Publicado: (2012)

Comparison of once daily radiotherapy to 60 Gy and twice daily radiotherapy to 45 Gy for limited stage small-cell lung cancer
por: Han, Dan, et al.
Publicado: (2015)

Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions
por: Ermiş, Ekin, et al.
Publicado: (2015)

Re-irradiation for local primary-recurrence esophageal squamous cell carcinoma treated with IMRT/VMAT
por: Xiang, Geng, et al.
Publicado: (2023)

Intensity-modulated radiotherapy with more than 60 Gy improved the survival of inoperable patients with locally advanced esophageal squamous cell carcinoma: A population-based real-world study
por: Zhang, Wei, et al.
Publicado: (2022)

High-dose re-irradiation of intracranial lesions – Efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose EQD calculation
por: Stiefel, I., et al.
Publicado: (2021)

Elective nodal dose of 60 Gy or 50 Gy in head and neck cancers: A matched pair analysis of outcomes and toxicity
por: Murthy, Vedang, et al.
Publicado: (2017)

Efficacy and safety of re-irradiation for locoregional esophageal squamous cell carcinoma recurrence after radiotherapy: a systematic review and meta-analysis
por: Lan, Kuntian, et al.
Publicado: (2022)

Re-Irradiation by Stereotactic Radiotherapy of Brain Metastases in the Case of Local Recurrence
por: Touati, Ruben, et al.
Publicado: (2023)

Biologically effective doses of 60–70Gy versus >70Gy of stereotactic body radiotherapy (SBRT) combined with chemotherapy in locally advanced pancreatic cancer: protocol of a single-centre, phase II clinical trial
por: Ye, Yusheng, et al.
Publicado: (2022)

Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study
por: Jingu, Keiichi, et al.
Publicado: (2017)

Toxicity of dose-escalated radiotherapy up to 84 Gy for prostate cancer
por: Rosenbrock, Johannes, et al.
Publicado: (2023)

Kidney Cell DNA Damage Caused By Combined Exposure To Volatile Anaesthetics and 1 Gy Or 2 Gy Radiotherapy Dose in Vivo
por: Benković, Vesna, et al.
Publicado: (2022)

Stereotactic body radiotherapy for re-irradiation of lung cancer recurrence with lower biological effective doses
por: Patel, Nisha R., et al.
Publicado: (2014)

Dose reduction trial from 60 Gy in 10 fractions to 54 Gy in 9 fractions schedule in high-dose-rate interstitial brachytherapy for early oral tongue cancer
por: Akiyama, Hironori, et al.
Publicado: (2012)

Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma
por: El Shafie, Rami A., et al.
Publicado: (2018)

Low dose 100 cGy irradiation as a potential therapy for pulmonary hypertension
por: Egan, Pamela C., et al.
Publicado: (2019)

Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non‐small cell lung cancer
por: Yang, Dan, et al.
Publicado: (2020)

Risk factors of esophageal fistula induced by re-radiotherapy for recurrent esophageal cancer with local primary site
por: Wang, Xinran, et al.
Publicado: (2022)

Re-irradiation with stereotactic radiotherapy for recurrent high-grade glial tumors
por: Soykut, Ela Delikgoz, et al.
Publicado: (2023)

Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors
por: Zhao, Yizhou, et al.
Publicado: (2020)

ESR investigation of sucrose radicals produced by 0.25−4.5 Gy doses of X-ray irradiation
por: Nakagawa, Kouichi, et al.
Publicado: (2014)

A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer
por: Lee, Sea-Won, et al.
Publicado: (2016)

Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis
por: Yamashita, Hideomi, et al.
Publicado: (2017)

Re-irradiation for locally recurrent refractory breast cancer
por: Merino, Tomas, et al.
Publicado: (2015)

Thoracic Re-irradiation for Locally Recurrent Lung Cancer
por: Aktan, Meryem, et al.
Publicado: (2016)

Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy
por: Mbeutcha, Aurélie, et al.
Publicado: (2017)

Acute Exacerbation of Tracheal Obstruction and Severe Respiratory Failure after a Single Dose of 2-Gy Irradiation for Squamous Cell Lung Carcinoma: A Case Report
por: Kawakado, Keita, et al.
Publicado: (2022)

100 Gy (60)Co γ-Ray Induced Novel Mutations in Tetraploid Wheat
por: Yang, Chuntao, et al.
Publicado: (2014)

High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC
por: Grambozov, Brane, et al.
Publicado: (2022)

Accelerated partial breast irradiation in a single 18 Gy fraction with high-dose-rate brachytherapy: preliminary results
por: Latorre, Javier Anchuelo, et al.
Publicado: (2018)

Efficacy and toxicity of re-irradiation for esophageal cancer patients with locoregional recurrence: a retrospective analysis
por: Zhao, Kaikai, et al.
Publicado: (2020)

Systemic Abscopal Effect of Low-dose Radiotherapy (2 Gy ×2) against Palatine Tonsil Follicular Lymphoma
por: Togitani, Kazuto, et al.
Publicado: (2022)

Definitive re-irradiation of locally recurrent esophageal cancer after trimodality therapy in patients with a poor performance status
por: W. Kim, Daniel, et al.
Publicado: (2020)

Impact on Radiation Dose and Volume V57 Gy of the Brain on Recurrence and Survival of Patients with Glioblastoma Multiformae
por: Stojkovski, Igor, et al.
Publicado: (2017)

Feasibility of carbon‐ion radiotherapy for re‐irradiation of locoregionally recurrent, metastatic, or secondary lung tumors
por: Hayashi, Kazuhiko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bovd68tpeg0f9ddq359g0c1ds2